Woerdenbag, H.J.; Olinga, P.; Kok, E.A.; Brugman, D.A.P.; van Ark, U.F.; Ramcharan, A.S.; Lebbink, P.W.; Hoogwater, F.J.H.; Knapen, D.G.; de Groot, D.J.A.;
et al. Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment. Cancers 2023, 15, 2119.
https://doi.org/10.3390/cancers15072119
AMA Style
Woerdenbag HJ, Olinga P, Kok EA, Brugman DAP, van Ark UF, Ramcharan AS, Lebbink PW, Hoogwater FJH, Knapen DG, de Groot DJA,
et al. Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment. Cancers. 2023; 15(7):2119.
https://doi.org/10.3390/cancers15072119
Chicago/Turabian Style
Woerdenbag, Herman J., Peter Olinga, Ellen A. Kok, Donald A. P. Brugman, Ulrike F. van Ark, Arwin S. Ramcharan, Paul W. Lebbink, Frederik J. H. Hoogwater, Daan G. Knapen, Derk Jan A. de Groot,
and et al. 2023. "Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment" Cancers 15, no. 7: 2119.
https://doi.org/10.3390/cancers15072119
APA Style
Woerdenbag, H. J., Olinga, P., Kok, E. A., Brugman, D. A. P., van Ark, U. F., Ramcharan, A. S., Lebbink, P. W., Hoogwater, F. J. H., Knapen, D. G., de Groot, D. J. A., & Nijkamp, M. W.
(2023). Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment. Cancers, 15(7), 2119.
https://doi.org/10.3390/cancers15072119
